High prevalence in developed regions and increasing incidence rate in emerging economies will
play major role in driving growth of the ulcerative colitis market
According to the study of CCFA, industrialized countries have highest incidence rate for
ulcerative colitis. This disease is most prevalent in urban areas than in rural areas, also it can
affect to any age group of people but most cases diagnosed are of the age in between 15 to 35.
According the stats of World Gastroenterology Organization (WGO), there is rising incidence
rate in emerging economies such as India. Due to changing diet and lifestyle pattern, the
emerging economies will show high growth rate in incidence rate of ulcerative colitis in the
near future.
According to data collected from various sources and compiled by Coherent Market Insights,
Europe have the highest annual rate of incidence worldwide, followed by North America and
the lowest in Asia and Middle East.
Download PDF Brochure Of This Research Report @
https://www.coherentmarketinsights.com/insight/request-pdf/238
Some leading drugs are used to reduce inflammation and swelling and to cure ulcerative colitis
are include Sulfasalazine (Azulfidine), Mesalamine (Asacol and Lialda), Balsalazide (Colazal), and
Olsalazine (Dipentum), Inflectra, Remsima, Adalimumab (Humira), Infliximab (Remicade).
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-
ready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com